Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up to 62% with a single infusion. Not only was the experimental treatment ...

A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...

A groundbreaking gene-editing therapy developed by Eli Lilly and Verve Therapeutics reduced "bad" LDL cholesterol by up to 62 ...